Stephen Corba has built a reputation over the past decade as a knowledgeable, results-driven professional in the pharmaceutical distribution and sales industry. After gaining 10 years of valuable experience at 2 leading pharmaceutical companies, AstraZeneca and Avenel Surgical & Pharmaceuticals, Corba accepted the position of President of Sales at Investigational Drug Delivery (IDD) in June 2011. A New Jersey-based company focusing solely on the sourcing of medical products for use in clinical research, IDD is becoming a leader in this sector of the industry. Working directly with clinical researchers and their pharmaceutical procurement staff, Stephen Corba and IDD strive to provide accurate and efficient service to their clients, delivering the products needed for important medical research.
After completing his education at Kaplan University and Rutgers University, Stephen Corba got his start in the pharmaceutical industry in 2001, when he was hired as a sales specialist at AstraZeneca. Drawing on his years of experience as an account manager for both The Coca-Cola Company and DHL Worldwide Express, Corba excelled at developing and maintaining business contact relationships, and quickly surpassed sales goals for his position at AstraZeneca. In 2003, Stephen Corba was promoted to Hospital Sales Specialist, responsible for sales of cardiovascular and central nervous system medications such as Seroquel, Merrem IV, Nexium IV, Crestor, Toprol XL, and Atacand to hospitals and teaching institutions in the northern New Jersey area. After more than six years with AstraZeneca, Corba accepted a position as a Regional Account Specialist with Avenel Surgical & Pharmaceuticals in 2007. Among his duties there, Stephen Corba was responsible for the retail sale of pharmaceutical products and surgical supplies, as well as working with Group Purchasing Operations (GPOs).